Outcomes Following Intolerance to Tacrolimus/Sirolimus Graft-versus-Host Disease Prophylaxis for Allogeneic Hematopoietic Cell Transplantation.
Mirza AS, Tandon A, Jenneman D, Cao S, Brimer T, Kumar A, Kidd M, Khimani F, Faramand R, Mishra A, Liu H, Nishihori T, Perez L, Lazaryan A, Bejanyan N, Nieder M, Anasetti C, Pidala J, Elmariah H.
Mirza AS, et al. Among authors: anasetti c.
Transplant Cell Ther. 2022 Apr;28(4):185.e1-185.e7. doi: 10.1016/j.jtct.2022.01.003. Epub 2022 Jan 10.
Transplant Cell Ther. 2022.
PMID: 35017119
Free article.